Literature DB >> 10718160

Detecting bipolar disorder among treatment-seeking substance abusers.

K L Sloan1, D Kivlahan, A J Saxon.   

Abstract

Bipolar disorder is increasingly recognized to have frequent comorbidity with substance use disorders, but may be difficult to diagnose among patients with active substance use. The purpose of this paper is to describe a brief, self-report form for the efficient detection of bipolar disorder. The 19-item form was piloted in 373 consecutive applicants for substance abuse treatment at an urban Veterans Affairs (VA) medical center. Results show reasonable internal consistency (alpha = .850) and high rates of manic symptomatology (36%), previous bipolar diagnosis (30%, 51% of whom report prior psychiatric hospitalization), and exposure to mood stabilizers (20%, 66% of whom reported therapeutic benefit). Comparison of nine different scoring algorithms with chart diagnosis as the validating criterion found that self-report of bipolar diagnosis was optimally sensitive. Either self-report of bipolar diagnosis with hospitalization or self-report of exposure to mood stabilizers with therapeutic response was optimally specific. Symptom self-report items had significantly poorer sensitivity and specificity (F = 7.60, p < .01). We conclude that questions pertaining to diagnostic and treatment history (especially hospitalization or therapeutic medication response) are considerably superior to symptom-based screening for clinically diagnosed bipolar disorder. Further work using structured interview as the diagnostic criterion is under way to validate this instrument.

Entities:  

Mesh:

Year:  2000        PMID: 10718160     DOI: 10.1081/ada-100100587

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  7 in total

1.  Treating depression and substance use: a randomized controlled trial.

Authors:  Sarah B Hunter; Katherine E Watkins; Kimberly A Hepner; Susan M Paddock; Brett A Ewing; Karen C Osilla; Suzanne Perry
Journal:  J Subst Abuse Treat       Date:  2012-02-01

2.  Does group cognitive-behavioral therapy module type moderate depression symptom changes in substance abuse treatment clients?

Authors:  Susan M Paddock; Sarah B Hunter; Thomas J Leininger
Journal:  J Subst Abuse Treat       Date:  2014-03-01

3.  An effectiveness trial of group cognitive behavioral therapy for patients with persistent depressive symptoms in substance abuse treatment.

Authors:  Katherine E Watkins; Sarah B Hunter; Kimberly A Hepner; Susan M Paddock; Erin de la Cruz; Annie J Zhou; Jim Gilmore
Journal:  Arch Gen Psychiatry       Date:  2011-06

4.  Do client attributes moderate the effectiveness of a group cognitive behavioral therapy for depression in addiction treatment?

Authors:  Sarah B Hunter; Susan M Paddock; Annie Zhou; Katherine E Watkins; Kimberly A Hepner
Journal:  J Behav Health Serv Res       Date:  2013-01       Impact factor: 1.505

5.  Training addiction counselors to implement CBT for depression.

Authors:  Kimberly A Hepner; Sarah B Hunter; Susan M Paddock; Annie J Zhou; Katherine E Watkins
Journal:  Adm Policy Ment Health       Date:  2011-07

6.  The moderating effects of group cognitive-behavioral therapy for depression among substance users.

Authors:  Sarah B Hunter; Katie Witkiewitz; Katherine E Watkins; Susan M Paddock; Kimberly A Hepner
Journal:  Psychol Addict Behav       Date:  2012-05-07

7.  Assessment of depressive symptom severity among patients with co-occurring bipolar disorder and substance dependence.

Authors:  Monika E Kolodziej; Margaret L Griffin; Rachel Bender; Roger D Weiss
Journal:  J Affect Disord       Date:  2007-06-28       Impact factor: 4.839

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.